Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Alka Jain
Chitotriosidase, a Marker of Innate Immunity, Is Elevated in Patients With Primary Breast Cancer
Cancer Biomarkers
Medicine
Cancer Research
Oncology
Genetics
Related publications
Collagen IV Levels Are Elevated in the Serum of Patients With Primary Breast Cancer Compared to Healthy Volunteers
British Journal of Cancer
Cancer Research
Oncology
Mammographic Density Reduction Is a Prognostic Marker of Response to Adjuvant Tamoxifen Therapy in Postmenopausal Patients With Breast Cancer
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Circulating Tumour Cell-Derived Plastin3 Is a Novel Marker for Predicting Long-Term Prognosis in Patients With Breast Cancer
British Journal of Cancer
Cancer Research
Oncology
Serum HER-2 Concentration in Patients With Primary Breast Cancer
Journal of Clinical Pathology
Medicine
Forensic Medicine
Pathology
Publisher Correction: Harnessing Innate Immunity in Cancer Therapy
Nature
Multidisciplinary
Excision of the Primary Tumour in Patients With Metastatic Breast Cancer: A Clinical Dilemma
Current Oncology
Oncology
ERR Is a Marker of Tamoxifen Response and Survival in Triple-Negative Breast Cancer
Clinical Cancer Research
Cancer Research
Oncology
Serum Expression of Β-Catenin Is a Potential Detection Marker in Patients With Colorectal Cancer
Disease Markers
Biochemistry
Medicine
Clinical Biochemistry
Molecular Biology
Genetics
BRG1 Is a Prognostic Marker and Potential Therapeutic Target in Human Breast Cancer
PLoS ONE
Multidisciplinary